Skip to main content
. 2017 Aug 9;6(11):e1356148. doi: 10.1080/2162402X.2017.1356148

Figure 2.

Figure 2.

Forest plots of prognostic value of CD3+ TILs on overall survival, disease-free survival and locoregional control in HPV-negative patients (A) and HPV-positive patients (B). No data were available for disease-free survival in HPV-positive patients.